Supplement
Conditions
Brief summary
This study will investigate the effects of lowering intraocular pressure by oral intake of Cordyceps cicadae mycelia, to provide evidence-based data for high intraocular pressure relief.
Detailed description
Study purpose This study investigated the effeicacy of oral Cordyceps cicadae mycelia for the relief of high intraocular pressure. Subjects 1. The total recruitment of subjects is 60 people, aged between 20 to 75 years. 2. Subjects with intraocular pressure more than or equal to 21 mmHg are included, irrespective of whether on us of Taflotan (saflutan). Methods 1\. Informed consents will be obtained from subjects first. The subjects with pre-test intraocular pressure over or equal 21 mm Hg are advised to orally take two capsules containing a total of 500 mg of Cordyceps cicadae mycelia. After 90 minutes, the subjects are evaluated for intraocular pressure. The pre-test and and post-intake intraocualr pressure and blood pressure data will be compared by paired t test for significant differences if any.
Interventions
DIETARY_SUPPLEMENTCordyceps Cicadae Mycelia
Cordyceps Cicadae Mycelia will be given to test its potential for alleviation of high intraocular pressure.
Sponsors
Grape King Bio Ltd.
Han-Hsin Chang
Study design
Allocation
NON_RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
NONE
Intervention model description
Two groups of subjects are subject to pre-test and post-test intraocular pressure measurements.
Eligibility
Sex/Gender
ALL
Age
20 Years to 75 Years
Healthy volunteers
No
Inclusion criteria
1. Age between 20 and 75 years old, regardless of gender. 2. Pre-test confirmation of high intraocular pressure. 3. Subjects should understand the trial and agree to join the project.
Exclusion criteria
1. Age under 20 or over 75 years. 2. Use intraocular pressure lowering drugs other than Taflotan (saflutan). 3. Using beta-blockers or diuretics. 4. Being pregnant. 5. Disabled individuals with specific diseases or malfunction, for example tumours at terminal stage, blindness. 6. Loss of self-consciousness and behavioral capacity. 7. Patients with major diseases. Withdrawal criteria All subjects may withdraw at any time without any reason. The act of withdraw does not affect rights for them to seek medical advice or treatments.
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Intraocular pressure | 0 minutes (before given Cordyceps Cicadae Mycelia) | Intraocular pressure of both eyes will be assessed |
| Blood pressure | 0 minutes (before given Cordyceps Cicadae Mycelia) | Both systolic and diastolic blood pressures will be assessed |
Countries
Taiwan
Outcome results
None listed